Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
A practical comparison of retirement index funds and target date funds, outlining when each may be the smarter pick for different retirement goals.
26,044 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Investors are asking what's going with Uber stock as the company diversifies beyond ridesharing. This guide breaks do...
The AI spending spree has some investors on edge. This guide explains why three big tech leaders may weather the stor...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
Recalls are part of the auto business, but the year, same ford problem: can still test investors. This article breaks...
Rigetti Computing just reported a sharp revenue jump. This article breaks down what a tripling revenue figure could m...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...
Hedge funds are loading up on big software names as AI fuels new growth avenues, even as margins come under pressure....
As shoppers stretch budgets, investors wonder: is walmart stock still safe? This deep dive examines Walmart's defensi...
Tax policy debates often clamp down on the top earners, but targeting high earners misguided choices can undermine st...
Real estate cycles linger, but today’s price pressures aren’t a carbon copy of 2008. Learn how Ken McElroy analyzes c...